Skip to main content
. 2022 Jul 25;12:885236. doi: 10.3389/fonc.2022.885236

Figure 3.

Figure 3

EGFR immunostaining and expression scores in OSCCs. (A): Shown are images of low [1+], moderate [2+], and strong [3+] EGFR expression scores. (B, C): Shown are Kaplan-Meier estimates of the overall survival (B) and progression free survival (C) of EGFR+ (2+ and 3+) and EGFR- (0 and 1+) patients. HR, hazard ratio; CI, 95% confidence interval.